<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02825277</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A01049-36</org_study_id>
    <nct_id>NCT02825277</nct_id>
  </id_info>
  <brief_title>Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies</brief_title>
  <acronym>EVUPA</acronym>
  <official_title>Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies: Third Trimester Quantification Using 3D Power Doppler With Comparison to Placental Vascular Morphology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction&#xD;
&#xD;
      Preeclampsia (PE) and intra-uterine growth restriction (IUGR) are two major pregnancy&#xD;
      complications related to chronic utero-placental hypoperfusion. Three-dimensional power&#xD;
      Doppler (3DPD) angiography has been used for the evaluation of utero-placental&#xD;
      vascularisation and three vascular indices have been calculated: the vascularisation index&#xD;
      (VI), flow index (FI) and vascularisation-FI (VFI). However, several technical endpoints&#xD;
      hinder the clinical use of 3DPD as physical characteristics and machine settings may affect&#xD;
      3DPD indices, and so its clinical significance is not yet clear.&#xD;
&#xD;
      Objectives&#xD;
&#xD;
      The primary objective is to better understand the clinical significance of 3DPD indices by&#xD;
      evaluating the relationship between these indices and placental morphometry. Secondary&#xD;
      objectives are (i) to determine the impact of machine settings and physical characteristics&#xD;
      on 3DPD indices, and (ii) to evaluate physio-pathological placental vascularisation patterns.&#xD;
&#xD;
      Methods and analysis&#xD;
&#xD;
      This is a prospective controlled study. We expect to include 112 women: 84 with normal&#xD;
      pregnancies and 28 with PE and/or IUGR (based on our former cohort study on 3DPD indices for&#xD;
      PE and/or IUGR prediction (unpublished data)). Within 72 h before planned or semi-urgent&#xD;
      caesarean section, utero-placental 3DPD images with five different machine settings will be&#xD;
      acquired. Placentas will be collected and examined after surgery and stereological indices&#xD;
      (volume density, surface density, length density) calculated. The 3DPD indices (VI, FI and&#xD;
      VFI) of the placenta and adjacent myometrium will be calculated. Correlation between Doppler&#xD;
      and morphological indices will be evaluated by Pearson or Spearman tests. Agreement between&#xD;
      3DPD indices and morphological indices will be assessed by Bland and Altman plots. The impact&#xD;
      of Doppler settings and maternal characteristics on 3DPD indices will be evaluated with a&#xD;
      multivariate linear regression model.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of 3D power Doppler indice : the vascularization index (VI)</measure>
    <time_frame>through study completion, an average of 42 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Measure of 3D power Doppler indice : blood flow (the flow index (FI)</measure>
    <time_frame>through study completion, an average of 42 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Measure of of 3D power Doppler indice : the vascularization-flow index (VFI)</measure>
    <time_frame>through study completion, an average of 42 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Measure of volume density (morphological analysis)</measure>
    <time_frame>through study completion, an average of 42 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Measure of surface density (morphological analysis)</measure>
    <time_frame>through study completion, an average of 42 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Preeclampsia</condition>
  <condition>Intra-uterine Growth Restriction</condition>
  <arm_group>
    <arm_group_label>pathological group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>pregnant women with preeclampsia and/or IUGR pregnancy with a planned or semi-urgent caesarean section or vaginal delivery will be recruited into this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>physiological group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>pregnant women with normal pregnancy with a planned caesarean section or vaginal delivery will be recruited into this study</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Doppler</intervention_name>
    <description>acquisition of 3D power Doppler of uteroplacental vascularization unit in 72h before delivery and morphological analysis for placenta</description>
    <arm_group_label>pathological group</arm_group_label>
    <arm_group_label>physiological group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        General Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥18 years and ≤65 years Fetal anomalies&#xD;
&#xD;
          -  Gestational age ≥30 gestational weeks&#xD;
&#xD;
          -  With social insurance&#xD;
&#xD;
          -  With written consent for participation&#xD;
&#xD;
          -  With medical examination&#xD;
&#xD;
        Physiological group Inclusion Criteria&#xD;
&#xD;
          -  Hospitalised pregnant women with scheduled or semi-urgent caesarean section according&#xD;
             to national HAS recommendations or Hospitalised pregnant women with scheduled vaginal&#xD;
             delivery.&#xD;
&#xD;
          -  Normal pregnancy issues&#xD;
&#xD;
          -  Normal fetal morphology&#xD;
&#xD;
        Pathological group Inclusion Criteria&#xD;
&#xD;
          -  Pregnant women with preeclampsia and/or IUGR pregnancy&#xD;
&#xD;
          -  Hospitalised pregnant women with scheduled or semi-urgent caesarean section or&#xD;
             hospitalised pregnant women with scheduled vaginal delivery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Fetal morphological abnormalities that may influence fetal circulation&#xD;
&#xD;
          -  Maternal or fetal vital urgency&#xD;
&#xD;
          -  Multiple pregnancy&#xD;
&#xD;
          -  Non-placental origin IUGR&#xD;
&#xD;
          -  Language barrier&#xD;
&#xD;
          -  Patient under legal protection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier MOREL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inserm U947, IADI, Nancy, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier MOREL, MD, PhD</last_name>
    <email>olivier.morel17@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aboubaker CHIRIFI</last_name>
    <email>a.cherifi@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pr Olivier MOREL</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier MOREL</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Duan J, Chabot-Lecoanet AC, Perdriolle-Galet E, Christov C, Hossu G, Cherifi A, Morel O. Utero-placental vascularisation in normal and preeclamptic and intra-uterine growth restriction pregnancies: third trimester quantification using 3D power Doppler with comparison to placental vascular morphology (EVUPA): a prospective controlled study. BMJ Open. 2016 Mar 31;6(3):e009909. doi: 10.1136/bmjopen-2015-009909.</citation>
    <PMID>27033959</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>June 30, 2016</study_first_submitted>
  <study_first_submitted_qc>July 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2016</study_first_posted>
  <last_update_submitted>July 4, 2016</last_update_submitted>
  <last_update_submitted_qc>July 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>3D Power Doppler</keyword>
  <keyword>uteroplacental vascularization</keyword>
  <keyword>preeclampsia</keyword>
  <keyword>intra-uterine growth restriction</keyword>
  <keyword>placental morphology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Fetal Growth Retardation</mesh_term>
    <mesh_term>Neovascularization, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

